These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 35963693)
1. Surgical treatment of the metastatic gastrointestinal stromal tumor after resistance to available tyrosine kinase inhibitors: A case report. Zhang H; Mu M; He X; Yin Y Asian J Surg; 2023 Feb; 46(2):937-938. PubMed ID: 35963693 [No Abstract] [Full Text] [Related]
2. The Role of Surgery in Metastatic Gastrointestinal Stromal Tumors. Keung EZ; Fairweather M; Raut CP Curr Treat Options Oncol; 2016 Feb; 17(2):8. PubMed ID: 26820287 [TBL] [Abstract][Full Text] [Related]
3. The Landmark Series: Systemic Therapy for Resectable Gastrointestinal Stromal Tumors. Keung EZ; Raut CP; Rutkowski P Ann Surg Oncol; 2020 Oct; 27(10):3659-3671. PubMed ID: 32734368 [TBL] [Abstract][Full Text] [Related]
4. Cytoreductive Surgery for Metastatic Gastrointestinal Stromal Tumors Treated With Tyrosine Kinase Inhibitors: A 2-institutional Analysis. Fairweather M; Balachandran VP; Li GZ; Bertagnolli MM; Antonescu C; Tap W; Singer S; DeMatteo RP; Raut CP Ann Surg; 2018 Aug; 268(2):296-302. PubMed ID: 28448384 [TBL] [Abstract][Full Text] [Related]
5. Lichenoid drug eruption caused by imatinib mesylate in a Chinese patient with gastrointestinal stromal tumor. Luo JR; Xiang XJ; Xiong JP Int J Clin Pharmacol Ther; 2016 Sep; 54(9):719-22. PubMed ID: 27345285 [TBL] [Abstract][Full Text] [Related]
6. Long-term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14-year, single-center experience. Kim JH; Ryu MH; Yoo C; Chae H; Na H; Beck M; Kim BS; Yoo MW; Yook JH; Kim BS; Kim KH; Kim CW; Kang YK Cancer Med; 2019 Mar; 8(3):1034-1043. PubMed ID: 30693663 [TBL] [Abstract][Full Text] [Related]
8. Liver resection for metastatic GIST tumor improves survival in the era of tyrosine kinase inhibitors: a systematic review and meta-analysis. Rahimi-Ardabily A; Murdande S; Dong M; Gu KW; Zhang B; Miller K; Aploks K; Da Dong X Langenbecks Arch Surg; 2023 Sep; 408(1):373. PubMed ID: 37740754 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of Long-Term Adjuvant Therapy With Imatinib Mesylate After Extensive Surgical Treatment for Ruptured Gastrointestinal Stromal Tumors of the Small Intestine With Peritoneal Metastases: A Case Report. Kimura T; Togawa T; Onishi K; Iida A; Sato Y; Goi T J Investig Med High Impact Case Rep; 2020; 8():2324709620970736. PubMed ID: 33228387 [TBL] [Abstract][Full Text] [Related]
11. A Case of Disseminated Intra-abdominal Gastrointestinal Stromal Tumor Managed with Low Dose Imatinib. Jang BH; Kim BW; Lim KJ; Kim BG; Park SM; Kim JS; Ji JS; Choi H Korean J Gastroenterol; 2015 Jun; 65(6):366-9. PubMed ID: 26087692 [TBL] [Abstract][Full Text] [Related]
12. Effective Downsizing of a Gastroesophageal GIST Using Neoadjuvant Imatinib Mesylate: a Case Report. Asif S; Gupta N; Gupta G; Mehta A; Singh S J Gastrointest Cancer; 2017 Jun; 48(2):198-200. PubMed ID: 27006070 [No Abstract] [Full Text] [Related]
13. [Significance of surgical treatment for recurrent and metastatic gastrointestinal stromal tumors]. Zhang XH; He YL Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):840-844. PubMed ID: 32927506 [TBL] [Abstract][Full Text] [Related]
14. Postoperative imatinib in patients with intermediate risk gastrointestinal stromal tumor. Wu X; Li J; Xu W; Gao J; Li Y; Shen L Future Oncol; 2018 Jul; 14(17):1721-1729. PubMed ID: 29969914 [TBL] [Abstract][Full Text] [Related]
15. Cytoreductive surgery offers prognostic benefits in metastatic gastrointestinal stromal tumors with generalized progression following imatinib therapy: a single institute retrospective study. Liu DN; Jia WW; Wang HY; Wu JH; Li CP; Hao CY BMC Surg; 2023 Jul; 23(1):189. PubMed ID: 37403109 [TBL] [Abstract][Full Text] [Related]
17. Imatinib-resistant gastrointestinal stromal tumors in the era of second- and third-line tyrosine kinase inhibitors: Does surgical resection have a role? Sutton TL; Walker BS; Billingsley KG; Sheppard BC; Corless CL; Heinrich MC; Mayo SC Surgery; 2021 Nov; 170(5):1481-1486. PubMed ID: 34090672 [TBL] [Abstract][Full Text] [Related]
19. [Molecular and histologic characteristics of secondary imatinib-resistant gastrointestinal stromal tumors]. Zheng S; Jia J; Pan YL; Tao DY; Lu HS Zhonghua Bing Li Xue Za Zhi; 2013 Jan; 42(1):42-3. PubMed ID: 23611272 [No Abstract] [Full Text] [Related]
20. Case of Imatinib Susceptibility to CYP3A4-Mediated Drug-Drug Interactions in a Patient With Gastrointestinal Stromal Tumor. Fujimiya T; Sugita H; Kin M; Funakoshi H; Kubota Y; Tsunoda T Am J Ther; 2024 Jan-Feb 01; 31(1):e66-e69. PubMed ID: 35792063 [No Abstract] [Full Text] [Related] [Next] [New Search]